RPTH Research Recap | Rivaroxaban in Acute Venous Thromboembolism: UK Prescribing Experience

RPTH Research Recap | The Psychological Impact of Pulmonary EmbolismПодробнее

MICHELLE Trial - Rivaroxaban vs No Anticoagulation - Critical Analysis- Pramil Cheriyath MDПодробнее

RPTH Research Recap: Laboratory-based inequity in thrombosis and hemostasis: review of the evidenceПодробнее

RPTH Recap: Thromboprophylaxis w/ rivaroxaban in patients w/ malignancy & central venous linesПодробнее

Alok Khorana: Rivaroxaban Prevents Cancer-Associated VTEПодробнее

RPTH Research Recap: Blood Clot Contraction: Mechanisms, Pathophysiology, and DiseaseПодробнее

RPTH Research Recap: Validation of the IMPROVE‐DD model for VTE among patients with COVID‐19Подробнее

RPTH Research Recap: Epidemiology of CVST and CVST with thrombocytopeniaПодробнее

RPTH Research Recap | Risk of VTE in Patients with COVID-19: A Systematic Review and Meta-analysisПодробнее

Rilzabrutinib: a novel promising BTK inhibitor being explored in ITPПодробнее

Using Xarelto to Treat Venous Thromboembolism In Everyday PracticeПодробнее

CASSINI: can we prevent thrombosis in cancer patients who are at risk?Подробнее

Apixaban reduced thromboembolism risk in cancer patientsПодробнее

Rivaroxaban vs enoxaparin for the Prevention of Venous Thromboembolism..Подробнее

Rivaroxaban beats aspirin for VTEПодробнее

SECRET trial: rivaroxaban for cerebral venous thrombosisПодробнее

Pirtobrutinib in R/R FL: results from the BRUIN studyПодробнее

Phase I/II BRUIN update: efficacy of pirtobrutinib in R/R Waldenström's macroglobulinemiaПодробнее